These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 5766091

  • 1. Dopa in Parkinson's disease.
    Rosenberg H.
    N Engl J Med; 1969 Mar 27; 280(13):730. PubMed ID: 5766091
    [No Abstract] [Full Text] [Related]

  • 2. Parkinson's disease: L-dopa treatment and handwriting area.
    Knopp W, Paulson G, Allen JN, Smeltzer D, Brown FD, Kose W.
    Curr Ther Res Clin Exp; 1970 Mar 27; 12(3):115-25. PubMed ID: 4985489
    [No Abstract] [Full Text] [Related]

  • 3. [Experiences with L-DOPA (Eldopal) treatment of 40 patients with Parkinson's disease].
    Postma JU, Stam FC, Meerlo HJ.
    Ned Tijdschr Geneeskd; 1971 Apr 17; 115(16):701-7. PubMed ID: 5551426
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [L-dopa effect in Parkinson's syndrome].
    Römer F, Bettag W, Bock WJ.
    Z Allgemeinmed; 1971 Feb 28; 47(6):281-3. PubMed ID: 5571715
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of Parkinson's syndrome with L-dopa].
    Ljung O.
    Lakartidningen; 1972 Jun 07; 69(24):2940-4. PubMed ID: 5037135
    [No Abstract] [Full Text] [Related]

  • 9. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA, De la Herrán J.
    Rev Clin Esp; 1970 Dec 31; 119(6):555-62. PubMed ID: 5509794
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [L-dopa and Parkinson's disease].
    Barbeau A.
    Union Med Can; 1970 Dec 31; 99(12):2195-7. PubMed ID: 5488646
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
    Weintraub MI, Van Woert MH.
    N Engl J Med; 1971 Feb 25; 284(8):412-5. PubMed ID: 5540479
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
    Lombardo L.
    Arch Invest Med (Mex); 1973 Feb 25; 4(3):215-24. PubMed ID: 4784173
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Parkinson's disease treated with L-dopa. Three-year follow-up report.
    Mones RJ.
    N Y State J Med; 1972 Nov 15; 72(22):2749-50. PubMed ID: 4510706
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.